Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDORMS Professor of Musculoskeletal and Surgical Science, David Beard, has been named National Institute of Health Research (NIHR) Senior Investigator.

David Beard

The NIHR describes its Senior Investigators as among the “most prominent and prestigious researchers” and “most outstanding leaders of patients and people-based research within the NIHR research community.”

David has been named Senior Investigator in recognition of his outstanding leadership in research.

On being recognised as a Senior Investigator, David said “It is always an honour and privilege to be personally named as an NIHR Senior Investigator and in some ways ratifies many years of dedication and hard work.  However, I would like this award to be also badged to anyone (in any capacity) who has worked or helped me along the way (including those who already have the award – and we have a good number in the Division!).  The NIHR is a truly excellent organisation and I am extremely proud to have been recognised by them.  It is going to help me continue to lead (hopefully) top quality health related research into the future.”

David is also Rosetrees Director of the Royal College of Surgeons (RCS) Surgical Intervention Trials Unit (SITU-NDORMS) and one of the five RCS Chairs in Surgical Trials in the UK. He is responsible for a portfolio of surgical and complex intervention trials, many as co-applicant and some as Chief Investigator.

Similar stories

£1.2M to improve diagnosis of emergency spinal condition

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Professor Chris Lavy appointed to WHO technical advisory group

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Gene variant links trigger finger and carpal tunnel syndrome

A new NDORMS study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.

Kennedy programmes support early career researchers

Since 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.

OCTRU collaboration boosts understanding of COVID vaccine response

Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).